| ￥1200 | |
| A02986-50 | |
|
|
|
|
|
|
|
|
|
| Specificity | This product is specific to MART1 |
| Host Species | Rabbit |
| Immunogen | A synthesized peptide derived from human MART1 |
| Species Reactivity | Human |
| Conjugate | Unconjugated |
| Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product. | |||||||||||||
|
|||||||||||||
| Form | Liquid |
| Storage Buffer | Supplied in 10mM phosphate buffered saline , pH 7.4, 150mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol. |
| Storage Instructions | Store at -20°C. This product is stable for 1 year upon receipt, when handled and stored as instructed. |
| Purification | Affinity-chromatography |
| Isotype | Rabbit IgG |
| Clonality | Monoclonal |
Western blot analysis of MLANA expression in Human melanoma tissue lysate. »
| Target Background | Involved in melanosome biogenesis by ensuring the stability of GPR143. Plays a vital role in the expression, stability, trafficking, and processing of melanocyte protein PMEL, which is critical to the formation of stage II melanosomes. |
| Synonyms | Antigen LB39-AA; Antigen SK29-AA; MAR1; MART-1; MART1; melan-A; Melanoma antigen recognized by T-cells 1; MLANA; Protein Melan-A; |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
